Compounds > catechin

catechin and Acute Relapsing Multiple Sclerosis

catechin has been researched along with Acute Relapsing Multiple Sclerosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Cuerda-Ballester, M; Drehmer, E; Ibáñez, V; Lopez-Rodríguez, MM; Ortí, JER; Platero, JL; Sancho, D1
Aktas, O; Bellmann-Strobl, J; Brandt, A; Dörr, J; Faiss, J; Groppa, S; Heesen, C; Heidrich, E; Hoffmann, F; Infante-Duarte, C; Körtgen, B; Lorenz, M; Paul, F; Pfüller, C; Radbruch, H; Rust, R; Siffrin, V; Wernecke, KD; Wuerfel, J; Zimmermann, B; Zipp, F1
Bock, M; Boschmann, M; Klug, L; Krannich, A; Lorenz, M; Mähler, A; Parreidt, N; Paul, F; Steiniger, J; Zimmermann, BF1

Trials

3 trial(s) available for catechin and Acute Relapsing Multiple Sclerosis

ArticleYear
The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients.
    Nutrients, 2020, Jan-23, Volume: 12, Issue:2

    Topics: Anxiety; Biomarkers; Body Mass Index; Catechin; Coconut Oil; Diet, Mediterranean; Dietary Supplements; Disability Evaluation; Emotions; Female; Humans; Interleukin-6; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Pilot Projects; Prospective Studies; Recovery of Function; Spain; Time Factors; Treatment Outcome

2020
Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial.
    Neurology(R) neuroimmunology & neuroinflammation, 2021, Volume: 8, Issue:3

    Topics: Adult; Brain; Catechin; Double-Blind Method; Glatiramer Acetate; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies; Young Adult

2021
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
    The American journal of clinical nutrition, 2015, Volume: 101, Issue:3

    Topics: Adult; Carbohydrate Metabolism; Catechin; Combined Modality Therapy; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Energy Metabolism; Female; Glatiramer Acetate; Humans; Immunosuppressive Agents; Lipid Metabolism; Male; Middle Aged; Motor Activity; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Neuroprotective Agents; Peptides; Postprandial Period; Severity of Illness Index; Sex Characteristics; Subcutaneous Fat, Abdominal

2015